13F filer · CIK 93751 ↗
State Street
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$1.67T
−17% on the quarter before
Positions
4,947
178 new · 150 sold out
Top 10
20.8%
of the value
Est. gain
−$307.25B
on stocks held all quarter
Est. return
−15.7%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from State Street's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 32% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Warner Bros Discovery Inc~$1.37BNew · 0.0% → 0.1%+102,279,013 shares
- Vici Pptys Inc~$840.6MAdded · 0.0% → 0.1%+27,894,859 shares
- Keurig Dr Pepper Inc~$579.2MAdded · 0.0% → 0.1%+16,279,787 shares
- Nextera Energy Inc~$414.5MAdded · 0.5% → 0.5%+5,351,422 shares
- Equinix~$414.2MAdded · 0.2% → 0.2%+630,477 shares
- onsemi~$332.2MAdded · 0.0% → 0.1%+6,603,825 shares
- Nvidia~$264.4MAdded · 1.3% → 0.9%+1,743,632 shares
- M & T Bk Corp~$232.8MAdded · 0.1% → 0.1%+1,460,870 shares
- Roblox~$208.0MAdded · 0.0% → 0.0%+6,330,861 shares
- Linde Plc~$198.2MAdded · 0.3% → 0.4%+689,308 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$2.14BCut · 5.3% → 4.9%−15,673,750 shares
- Berkshire Hathaway Inc Del~$1.81BCut · 1.4% → 1.2%−6,618,871 shares
- Microsoft~$1.68BCut · 4.6% → 4.5%−6,540,249 shares
- Exxon Mobil Corp~$1.42BCut · 1.0% → 1.2%−16,600,117 shares
- Cerner Corp~$1.28BSold out · 0.1% → 0.0%−13,602,628 shares
- Jpmorgan Chase & Co~$1.20BCut · 0.9% → 0.9%−10,634,258 shares
- Peoples United Financial Inc~$968.7MSold out · 0.0% → 0.0%−48,461,302 shares
- Bk Of America Corp~$780.1MCut · 0.7% → 0.6%−25,058,552 shares
- Wells Fargo Co New~$613.6MCut · 0.4% → 0.4%−15,665,959 shares
- Morgan Stanley~$589.3MCut · 0.6% → 0.6%−7,747,790 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −2.6% · price −21.7% | 4.9% | $81.78B | −$22.66B | ||||||||
| MicrosoftCOM · shares −2.2% · price −16.7% | 4.5% | $75.39B | −$15.11B | ||||||||
| AmazonCOM · shares −1.5% · price −34.8% | 2.1% | $34.70B | −$18.55B | ||||||||
| Johnson & JohnsonCOM · shares −0.8% · price +0.2% | 1.5% | $25.04B | +$39.5M | ||||||||
| AlphabetCAP STK CL A · shares −2.3% · price −21.6% | 1.4% | $23.65B | −$6.54B | ||||||||
| Unitedhealth Group IncCOM · shares −0.9% · price +0.7% | 1.4% | $23.56B | +$167.9M | ||||||||
| AlphabetCAP STK CL C · shares −2.5% · price −21.7% | 1.3% | $22.07B | −$6.11B | ||||||||
| TeslaCOM · shares −2.0% · price −37.5% | 1.3% | $21.41B | −$12.85B | ||||||||
| Exxon Mobil CorpCOM · shares −6.6% · price +3.7% | 1.2% | $20.09B | +$715.4M | ||||||||
| Chevron Corp NewCOM · shares −0.5% · price −11.1% | 1.2% | $19.87B | −$2.48B | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares −8.4% · price −22.6% | 1.2% | $19.69B | −$5.76B | ||||||||
| Lockheed Martin CorpCOM · shares −0.7% · price −2.6% | 0.99% | $16.55B | −$440.4M | ||||||||
| Pfizer IncCOM · shares +0.1% · price +1.3% | 0.90% | $15.06B | +$189.3M | ||||||||
| Procter And Gamble CoCOM · shares −1.5% · price −5.9% | 0.90% | $14.95B | −$936.6M | ||||||||
| NvidiaCOM · shares +1.8% · price −44.4% | 0.89% | $14.84B | −$11.65B | ||||||||
| Jpmorgan Chase & CoCOM · shares −7.6% · price −17.4% | 0.88% | $14.65B | −$3.09B | ||||||||
| MetaCL A · shares −3.1% · price −27.5% | 0.87% | $14.49B | −$5.49B | ||||||||
| Visa Inc.COM CL A · shares −3.3% · price −11.2% | 0.83% | $13.93B | −$1.76B | ||||||||
| Home Depot IncCOM · shares +0.6% · price −8.4% | 0.75% | $12.59B | −$1.14B | ||||||||
| Raytheon Technologies CorpCOM · shares −1.7% · price −3.0% | 0.75% | $12.45B | −$383.5M | ||||||||
| Abbvie IncCOM · shares −1.2% · price −5.5% | 0.71% | $11.81B | −$690.2M | ||||||||
| Eli LillyCOM · shares −1.0% · price +13.2% | 0.65% | $10.83B | +$1.27B | ||||||||
| Merck & Co IncCOM · shares −0.4% · price +11.0% | 0.65% | $10.82B | +$1.07B | ||||||||
| Coca Cola CoCOM · shares −0.7% · price +1.4% | 0.65% | $10.81B | +$154.4M | ||||||||
| MastercardCL A · shares −3.3% · price −11.7% | 0.64% | $10.64B | −$1.41B | ||||||||
| Total · 4,947 positions | 100% | $1.67T | −$307.25B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 4,571 stocks held throughout, down $307.25B (−15.7%).
- Eli Lilly+$1.27B+13%
- Merck & Co Inc+$1.07B+11%
- Exxon Mobil Corp+$715.4M+4%
- IBM+$591.7M+9%
- Northrop Grumman Corp+$446.5M+7%
- Nvidia−$11.65B−44%
- Tesla−$12.85B−38%
- Microsoft−$15.11B−17%
- Amazon20:1 split−$18.55B−35%
- Apple−$22.66B−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 53 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Sep 22, 2026 (amended) | $3.38T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.90T−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $2.98T+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.88T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.67T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $2.43T−4% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $2.53T+3% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.46T+7% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.29T+2% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.24T+9% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $2.06T+14% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $1.80T−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.90T+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $1.77T+4% | SEC ↗ |
| Q4 2022 | May 15, 2023 (amended) | $1.70T+8% | SEC ↗ |
| Q3 2022 | Nov 15, 2022 | $1.58T−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $1.67T−17% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $2.02T−4% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $2.11T+11% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $1.89T−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $1.90T+9% | SEC ↗ |
| Q1 2021 | Jul 9, 2021 (amended) | $1.74T+7% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $1.63T+12% | SEC ↗ |
| Q3 2020 | Nov 10, 2020 | $1.46T+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $1.38T+20% | SEC ↗ |
| Q1 2020 | Jun 19, 2020 (amended) | $1.14T−22% | SEC ↗ |
| Q4 2019 | Feb 6, 2020 | $1.46T+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 (amended) | $1.34T+0% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $1.34T+5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $1.28T+17% | SEC ↗ |
| Q4 2018 | Feb 12, 2019 | $1.10T−16% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $1.30T+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $1.20T+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $1.18T−5% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $1.24T+7% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $1.16T+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $1.13T+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $1.12T+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $1.06T+7% | SEC ↗ |
| Q3 2016 | Jan 13, 2017 (amended) | $992.21B+7% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $930.88B+1% | SEC ↗ |
| Q1 2016 | May 20, 2016 (amended) | $924.92B | SEC ↗ |